Spero Therapeutics, Inc.
SPRO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$69 | $23 | -$46 | -$90 |
| Dep. & Amort. | $0 | $0 | $2 | $1 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $8 | $8 | $0 | $0 |
| Change in WC | $36 | -$70 | $22 | $13 |
| Other Non-Cash | $1 | $6 | $15 | $11 |
| Operating Cash Flow | -$23 | -$33 | -$8 | -$64 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | -$27 | -$44 |
| Inv. Sales/Matur. | $0 | $0 | $61 | $52 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $34 | $8 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | -$54 | $47 |
| Stock Issued | $0 | $0 | $25 | $37 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $0 | $0 | -$30 | $84 |
| Forex Effect | $0 | $0 | $0 | -$0 |
| Net Chg. in Cash | -$23 | -$33 | -$3 | $27 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $76 | $109 | $113 | $85 |
| End Cash | $53 | $76 | $109 | $113 |
| Free Cash Flow | -$23 | -$33 | -$8 | $0 |